More than 98% of cattle have been injected in Thailand, confident that lumbian skin disease will be healed within 3 months.

Published 2021년 8월 14일

Tridge summary

The Thai Cabinet has allocated a budget of 684,218,000 baht to combat Lumpy Skin disease in cattle and buffalo, as proposed by the Ministry of Agriculture and Cooperatives. This includes funding for the purchase of 5 million vaccines, with half expected to arrive in Thailand within 15 days. The Department of Livestock Development has a plan in place to vaccinate all cattle farmers and buffalo owners, aiming for herd immunity. So far, 349,738 cows have received vaccination, representing 98% of those injected. The disease has affected a total of 561,124 animals, with 343,015 recoveries and 43,121 deaths. The number of new sick animals is expected to decrease significantly with targeted vaccination, and the disease is projected to be eradicated within three months.
Disclaimer:The above summary was generated by Tridge's proprietary AI model for informational purposes.

Original content

Veterinarian Sorawit Thanito, Director-General of the Department of Livestock Development, revealed that according to the Cabinet's approval of the budget for the fiscal year 2021, the central budget, the list of reserves for in case of emergency or necessity To control Lumpy Skin in cattle, buffalo, as proposed by the Ministry of Agriculture and Cooperatives in the budget amount of 684,218,000 baht for the cost of controlling Lumpy Skin in cattle and buffalo. Lumpy skin disease in cattle and buffaloes. As for the 5 million doses of vaccine approved for the purchase budget, Currently, the Department of Livestock Development has a plan to manage all 5 million doses of vaccine, ready for all provincial livestock to prepare a vaccination plan already. Ready to vaccinate cattle farmers' buffaloes As for vaccines that the Department of Livestock Development has ordered from foreign manufacturers in the amount of 5 million doses, 2.5 million doses have been expedited to arrive in ...
Source: Pasusart

Would you like more in-depth insights?

Gain access to detailed market analysis tailored to your business needs.
By clicking “Accept Cookies,” I agree to provide cookies for statistical and personalized preference purposes. To learn more about our cookies, please read our Privacy Policy.